SFS
BHVN

Sowell Financial Services’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Sowell Financial Services’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,221
Closed -$86K – 3230
2021
Q1 		$86K Sell
1,221
-197
-14% -$15.9K ﹤0.01% 1434
2020
Q4 		$122K Buy
1,418
+120
+9% +$10.2K 0.01% 1074
2020
Q3 		$84K Sell
1,298
-878
-40% -$57.5K ﹤0.01% 1044
2020
Q2 		$159K Buy
2,176
+1,250
+135% +$66.5K 0.01% 804
2020
Q1 		$32K Sell
926
-359
-28% -$16.4K ﹤0.01% 1224
2019
Q4 		$70K Buy
1,285
+1,045
+435% +$51.7K 0.01% 1032
2019
Q3 		$10K Buy
+240
New +$10.1K ﹤0.01% 1551

Other funds holding BHVN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Sowell Financial Services's BHVN Position: Q2 2021 in Review

Sowell Financial Services sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2021, closing a stake of 1,221 shares — an estimated $86K sold.

Sowell Financial Services first reported a position in BHVN in Q3 2019 and held it in 7 quarters. The position peaked at $159K in Q2 2020. 223 funds tracked by Wall St. Rank hold BHVN as of Q2 2021.

  • Sowell Financial Services reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,221 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2021, an estimated $86K.
  • Sowell Financial Services first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $159K in Q2 2020.
  • 223 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.